| Metric | Value | Detail |
|---|---|---|
| Revenue | $10.1B | +20.5% YoY |
| Net income | $2.9B | 28.6% margin |
| Gross margin | 66.0% | Gross profit / revenue |
| Operating margin | 29.3% | Operating income / revenue |
| Return on equity | 16% | Net income / equity |
| Return on assets | 14% | Net income / assets |
| Revenue growth (YoY) | +20.5% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | +17.4% | Compound annual |
| Diluted EPS | $8.00 | FY2025 |
| Debt-to-equity | n/a | Long-term debt / equity |
| Current ratio | 4.87 | Current assets / liabilities |
| Cash & equivalents | $3.4B | Balance sheet |
| Total assets | $20.5B | FY2025 year-end |
| Shareholders’ equity | $17.9B | FY2025 year-end |
| Share price | $406.78 | Delayed · 2026-07-10 |
| Market cap | $144.1B | Price × shares outstanding |
| P/E ratio | 50.1 | Market cap / net income |
| P/S ratio | 14.3 | Market cap / revenue |
| Dividend yield | n/a | Dividend / price |
Stock fundamentals · FY2025 · SEC 10-K data
Intuitive Surgical, Inc. (ISRG) stock fundamentals
Intuitive Surgical, Inc. (ISRG) reported $10.1B in revenue and $2.9B in net income in fiscal 2025, a 28.6% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $144.1B at a delayed share price. It scores 68/100 on WealthyBud's Investor Score, ranking #13 of 100 covered companies. Score is research, not investment advice.
Revenue (FY2025)
$10.1B
▲ +20.5% YoY
Net income
$2.9B
28.6% net margin
Market cap
$144.1B
Price $406.78 · delayed
P/E ratio
50.1
Price / earnings
Return on equity
16%
Net income / equity
Investor Score
68/100
#13 of 100 covered
Intuitive Surgical, Inc. fundamentals at a glance
The table summarizes Intuitive Surgical, Inc.'s key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is Intuitive Surgical, Inc.?
Intuitive Surgical, Inc. runs a 28.6% net margin and 66.0% gross margin in fiscal 2025, turning $10.1B of revenue into $2.9B of profit. Return on equity is 16% and return on assets 14%.
Is Intuitive Surgical, Inc. growing?
Intuitive Surgical, Inc.'s revenue changed +20.5% in fiscal 2025 and compounded at +17.4% a year over three years, reaching $10.1B. Diluted earnings per share were $8.00 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $5.7B | n/a |
| 2022 | $6.2B | +9.0% |
| 2023 | $7.1B | +14.5% |
| 2024 | $8.4B | +17.2% |
| 2025 | $10.1B | +20.5% |
How is Intuitive Surgical, Inc. valued?
Intuitive Surgical, Inc. carries a market capitalization of $144.1B at a delayed share price of $406.78, trading at a 50.1 price-to-earnings ratio and 14.3 price-to-sales. Its Value subscore is 18/100 across the covered universe.
How financially healthy is Intuitive Surgical, Inc.?
Intuitive Surgical, Inc. ended fiscal 2025 with $3.4B in cash, a debt-to-equity ratio of n/a and a current ratio of 4.87. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is Intuitive Surgical, Inc.'s Investor Score?
Intuitive Surgical, Inc. scores 68/100 on WealthyBud's Investor Score, #13 of 100 covered companies as of 2026-07-10. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Investor Score
68/100
#13 of 100 covered companies
Subscores are percentile ranks (0–100) across the 100 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
Intuitive Surgical, Inc. (ISRG) stock FAQ
How much revenue does Intuitive Surgical, Inc. make?
Intuitive Surgical, Inc. (ISRG) reported $10.1B in revenue in fiscal 2025, +20.5% versus the prior year, according to its SEC 10-K filing. Over the past three years its revenue has compounded at +17.4% a year.
Is Intuitive Surgical, Inc. profitable?
Yes. Intuitive Surgical, Inc. earned $2.9B in net income in fiscal 2025, a 28.6% net margin. Its return on equity was 16% and return on assets 14%, based on figures from its latest 10-K.
How fast is Intuitive Surgical, Inc. growing?
Intuitive Surgical, Inc.'s revenue changed +20.5% year over year in fiscal 2025 and compounded at +17.4% annually over three years. Growth is one of four inputs to its WealthyBud Investor Score, scored 82/100 versus the covered universe.
What is Intuitive Surgical, Inc.'s market cap and P/E ratio?
Intuitive Surgical, Inc. has a market capitalization of $144.1B at a delayed share price of $406.78, trading at a price-to-earnings ratio of 50.1 and price-to-sales of 14.3. Its dividend yield is n/a. Prices are delayed and illustrative.
What is Intuitive Surgical, Inc.'s WealthyBud Investor Score?
Intuitive Surgical, Inc. scores 68/100, ranking #13 of 100 covered companies as of 2026-07-10. The score is a percentile blend of growth (82), profitability (73), returns on capital (57), balance-sheet strength (99) and value (18). It is a research opinion, not investment advice.
Where does this Intuitive Surgical, Inc. financial data come from?
Fundamentals come from Intuitive Surgical, Inc.'s annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from Intuitive Surgical, Inc.’s FY2025 Form 10-K filed with the
SEC (EDGAR, public domain), retrieved 2026-07-10. Share price is a delayed end-of-day quote; market cap, P/E, P/S
and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion.
Not investment advice.